Published Date:
Version 1.0 of SENDIG-DART is available for provisional use and supports study data typically found in embryo-fetal developmental (EFD) toxicity studies. It is based on, and should be used in accordance with, the SENDIG v3.1 for single-dose general toxicology, repeat-dose general toxicology, and carcinogenicity studies. While SENDIG-DART v1.0 focuses on EFD, other study designs will be covered in future releases.